Clearance Summary
SOLITAIRE 2 REVASCULARIZATION DEVICE received FDA 510(k) clearance under submission number K123378, sponsored by Micro Therapeutics Dba Ev3 Neurovascular. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2012-11-30.
- Submission: K123378
- Applicant / Sponsor: Micro Therapeutics Dba Ev3 Neurovascular
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1250
- Decision date: 2012-11-30
Classification & Regulation
This clearance is catalogued under FDA product code NRY and 21 CFR 870.1250, within the Cardiovascular review panel as a Class II device.